Trump signed an executive order reclassifying marijuana as a less dangerous drug. The change could help the industry without legalizing the drug.

The move to Schedule III marks the greatest change to U.S. drug laws since 1970 and represents a new future for the $32 billion cannabis industry.

The order to place cannabis in the same category as Tylenol with codeine would mark the most significant change in US drug policy since 1971.